Journal of Substance Abuse Treatment 2012;42(4):438–445.
Edmund J. Bini, MD, MPH (VA New York Harbor Healthcare System, NY Node), Steven Allan Kritz, MD (Addiction Research and Treatment Corporation, NY Node), Lawrence S. Brown Jr., MD, MPH (Addiction Research and Treatment Corporation, NY Node), James A. Robinson, MEd (Nathan Kline Institute for Psychiatric Research, NY/LI Node), Donald A. Calsyn, PhD (Alcohol & Drug Abuse Institute, UW, PN Node), Donald Alderson, MS (New York State Psychiatric Institute, NY Node), Kathlene Tracy, PhD(NYU School of Medicine, GNY Node), Patrick McAuliffe, MBA, LADC (Connecticut Renaissance, Inc., NE Node), Cheryl Smith, MD (NY State Department of Health, NY Node), John Rotrosen, MD (New York University, NY Node).
Although substance abuse treatment programs are important contact points for providing health services for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, availability of services in these programs has not been well characterized. This study evaluated the spectrum of HBV and HCV services offered by substance abuse treatment programs within the National Drug Abuse Treatment Clinical Trials Network (CTN). A survey of substance abuse treatment program administrators covered availability of testing for HBV and HCV, hepatitis A virus (HAV) and HBV immunization, and HCV medical and nonmedical services. There were also questions covering clarity of guidelines for HBV and HCV testing and HAV and HBV immunization. Differences betwseen methadone and nonmethadone programs were examined.
Conclusions: Despite the importance of substance abuse in sustaining the hepatitis epidemics, few programs offer comprehensive HBV and HCV testing or HCV health care services. Because substance abuse treatment programs are an important point of contact to provide risk-reduction counseling, testing, and treatment for these infections, these identified shortcomings provide opportunities for public health intervention. (Article (Peer-Reviewed), PDF, English, 2011)
Keywords: Community health services | Health services research | Hepatitis B | Hepatitis C | Sexually transmitted diseases | Journal of Substance Abuse Treatment (journal)
Document No: 768, PMID: 22035702, PMCID: PMC3272317.
Submitted by CTN Dissemination Librarians, 10/31/2011.